(PDF) P1.01-01 ROS1-Positive Non-Small Cell Lung Cancer:

P1.01-01 ROS1-Positive Non-Small Cell Lung Cancer: Real-World Data in Korea

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.557

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P1.01-113 Analysis of Clinicopathological Features and Clinical Efficacy of Crizotinib in ROS1 Positive Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience From Turkey

Journal of Thoracic Oncology

Respiratory Medicine

English

Real-World Data on Nivolumab Treatment of Non-Small Cell Lung Cancer

Acta Oncologica

Nuclear Medicine

English

Detection of ROS1-positive Non-Small Cell Lung Cancer on Cytological Specimens Using Immunocytochemistry

Cancer cytopathology

Cancer Research

English

P2.01-50 Thromboembolism in ROS1 Rearranged Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer

Clinical Lung Cancer

Cancer Research

Respiratory Medicine

English

Real-World Costs of Laboratory Tests for Non-Small Cell Lung Cancer

Value in Health

Occupational Health

English

P1.01-78 the Incidence of Brain Metastases in ROS1-Rearranged Non-Small Cell Lung Cancer at Diagnosis and Following Progression on Crizotinib

Journal of Thoracic Oncology

Respiratory Medicine

English

OA09 Preliminary Clinical Activity of Repotrectinib (TPX-0005) in Advanced ROS1 Fusion-Positive Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English